Meiyan Yang
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 15
- Advanced Drug Delivery Systems 6
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 16
- Co-authors
- Chunsheng Gao (37 shared papers)Wei Gong (33 shared papers)Yuli Wang (17 shared papers)Zhiping Li (13 shared papers)Yang Yang (11 shared papers)Ren‐Xi Zhuo (5 shared papers)Chuan‐Jun Liu (5 shared papers)Chunhong Gao (4 shared papers)
- Journals
- Current Drug Delivery (6 papers)ACS Applied Materials & Interfaces (5 papers)International Journal of Pharmaceutics (4 papers)Pharmaceutics (4 papers)Journal of Controlled Release (4 papers)
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Meiyan Yang
69 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 129
- Pharmaceutical Science 289
- Biomaterials 551
- Molecular Medicine 95
- Biomedical Engineering 556
- Surfaces, Coatings and Films 75
Countries citing papers authored by Meiyan Yang
This map shows the geographic impact of Meiyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyan Yang more than expected).
Fields of papers citing papers by Meiyan Yang
This network shows the impact of papers produced by Meiyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyan Yang. The network helps show where Meiyan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiyan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 144 | |
| 2 | 2020 | 132 | |
| 3 | 2021 | 115 | |
| 4 | 2014 | 103 | |
| 5 | 2015 | 82 | |
| 6 | 2021 | 79 | |
| 7 | 2021 | 69 | |
| 8 | 2015 | 64 | |
| 9 | 2022 | 59 | |
| 10 | 2017 | 58 | |
| 11 | 2022 | 55 | |
| 12 | 2018 | 54 | |
| 13 | 2014 | 50 | |
| 14 | 2018 | 49 | |
| 15 | 2023 | 49 | |
| 16 | 2014 | 46 | |
| 17 | 2021 | 46 | |
| 18 | 2018 | 36 | |
| 19 | 2021 | 36 | |
| 20 | 2020 | 35 |
About Meiyan Yang
Meiyan Yang is a scholar working on Pharmaceutical Science, Biomaterials, Organic Chemistry, Molecular Medicine and Molecular Biology, having authored 72 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (16 papers), Drug Solubulity and Delivery Systems (15 papers), RNA Interference and Gene Delivery (8 papers), Crystallization and Solubility Studies (7 papers), Advanced Drug Delivery Systems (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Fatty Acid Research and Health (4 papers). The work is most often cited by research in Pharmaceutical Science (289 citations), Biomaterials (551 citations), Molecular Medicine (95 citations), Biomedical Engineering (556 citations) and Surfaces, Coatings and Films (75 citations). Meiyan Yang has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Chunsheng Gao, Wei Gong, Yuli Wang, Zhiping Li, Yang Yang, Ren‐Xi Zhuo, Chuan‐Jun Liu, Chunhong Gao, Zhiping Li and Ye Feng. Their work appears in journals such as Current Drug Delivery, ACS Applied Materials & Interfaces, International Journal of Pharmaceutics, Pharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.